FISHER & PAYKEL HEAL

FPH

End-of-day quote - 10/28
35.96NZD	+3.90%

Prev.	34.6100
Open	34.5100
High	36.4900
Low	34.5000
Volume	1 475 401

1d ago	Australian shares inch lower on virus, U.S. stimulus worries
7d ago	Australia shares close lower as U.S. stimulus appears elusive
10/15	Fisher & Paykel Healthcare : to announce half year results on 25 November 2020
09/22	Australia shares end lower as rising COVID-19 cases stoke lockdown worries

	Short Term	Mid-Term	Long Term
Trend	Bullish	Neutral	Bullish
Resistance	36,4	37,7	37,7
Spread/Res.	-1,2%	-4,6%	-4,6%
Spread/Supp.	5,6%	29%	28%
Support	34,0	27,8	28,1

Sales 2021	1 647 M 1 091 M 1 091 M
Net income 2021	397 M 263 M 263 M
Net cash 2021	66,5 M 44,1 M 44,1 M
P/E ratio 2021	52,1x
Yield 2021	1,10%

Capitalization	21 303 M 14 182 M 14 111 M
EV / Sales 2021	12,9x
EV / Sales 2022	12,7x
Nbr of Employees	4 751
Free-Float	99,8%

Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets medical device products and systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep apnea. The Companyâ€™s segment includes North America, which includes all activities...

>> Read more

Sector :

Medical Equipment, Supplies & Distribution - NEC

Calendar :

2020-11-24 Earnings Release

Trading Rating :

Investor Rating :

Mean consensus	UNDERPERFORM
Number of Analysts	9
Average target price	28,51 NZD
Last Close Price	35,96 NZD
Spread / Highest target	4,53%
Spread / Average Target	-20,7%
Spread / Lowest Target	-43,8%